|
Jun 25
|
AstraZeneca’s trial of Imfinzi for lung cancer failed to meet primary endpoint
|
|
Jun 22
|
3 No-Brainer Stocks to Buy for Under $100 Right Now
|
|
Jun 21
|
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
|
|
Jun 21
|
AstraZeneca’s Truqap and Faslodex combo receives approval in EU
|
|
Jun 20
|
Why Wall Street Is Chasing Ozempic Wannabes
|
|
Jun 11
|
Why AstraZeneca plc (NASDAQ:AZN) is Investors’ One of Favorite International Dividend Stock?
|
|
Jun 10
|
Astrazeneca (AZN) Advances But Underperforms Market: Key Facts
|
|
Jun 10
|
Meet The International Megacaps That 'Match Or Surpass' Magnificent Seven Stocks
|
|
Jun 10
|
AstraZeneca's (AZN) Tagrisso sNDA Gets FDA's Priority Tag
|
|
Jun 10
|
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
|
|
Jun 10
|
TAGRISSO® (osimertinib) granted Priority Review in the US for patients with unresectable, Stage III EGFR-mutated lung cancer
|
|
Jun 10
|
Most CEOs are defeating attempts to vote down their pay. Can Tesla's Elon Musk do the same?
|
|
Jun 7
|
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
|
|
Jun 7
|
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
|
|
Jun 6
|
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
|
|
Jun 5
|
AstraZeneca completes Fusion Pharmaceuticals acquisition
|
|
May 12
|
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
|
|
May 10
|
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
|
|
May 10
|
Catalyst's New CEO Has Big Ideas For The Small Biotech
|
|
May 8
|
Update: AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents
|